1. Home
  2. FRSX vs MBIO Comparison

FRSX vs MBIO Comparison

Compare FRSX & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

N/A

Current Price

$1.08

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.47

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSX
MBIO
Founded
N/A
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.1M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
FRSX
MBIO
Price
$1.08
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 85.6K
25.8K
Earning Date
10-06-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$90.14
N/A
Revenue Next Year
$154.13
$405.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.47
52 Week High
$3.00
$1.84

Technical Indicators

Market Signals
Indicator
FRSX
MBIO
Relative Strength Index (RSI) 40.67 34.45
Support Level $1.05 $0.47
Resistance Level $1.14 $0.56
Average True Range (ATR) 0.09 0.03
MACD 0.00 -0.00
Stochastic Oscillator 14.29 10.21

Price Performance

Historical Comparison
FRSX
MBIO

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: